A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK

Data sources

• Data source(s):
  Clinical Practice Research Datalink (CPRD) GOLD

  The Valencia Health System Integrated Database

  The Information System for Research in Primary Care (SIDIAP)

  EpiChron Cohort

  Système National des Données de Santé (French national health system main database)
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

  Population registry

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

CDM Mappings

• CDM name:
  ConcepTION CDM
• CDM website:
  https://www.imi-conception.eu/
• CDM release frequency:
  6 months

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  No